TYBR is developing a hydrogel spray to prevent internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the 1.8m Americans who suffer tendon or ligament injuries each year.
Tim Keane is a co-founder & CEO of TYBR Health. He has expertise in regenerative medicine and biomaterials and over 30 publications to support the science behind TYBR's technology. Prior to co-founding TYBR, Tim completed a Biodesign Fellowship at Texas Medical Center. He has a BS in chemical engineering and PhD in bioengineering from the University of Pittsburgh and completed post-doctoral fellowships at Imperial College London.
Alex is a cofounder and TYBR’s CTO. He has a BS and MEng in Biomedical Engineering from Texas A&M University and a PhD in Mechanical Engineering from University of Houston. He has nearly a decade of experience in medical device development for dialysis access, vaginal dilators, and ventricular assist pump design. At TYBR, he prototypes the delivery system for ECM spray, plans studies, and manages manufacturability & cost control of the delivery device.